Additional studies are needed to define whether aromatase inhibition has therapeutic value in males and in brain metastases from lung cancer and melanoma, and to further elucidate the mechanisms by which sex‐hormones alter early and late stages of brain metastatic colonization. This evidence concerns the gene CYP19A1 and lung cancer.